Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Supernus Pharm (SUPN)

55 -1.1 (-1.96%)

05-21 16:00

Open:

56.05

Pre. Close:

56.1

High:

56.05

Low:

52.95

Volume:

1,115,377

Market Cap:

2849M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

56.169 - 56.507

56.507 - 56.758

Low:

52.172 - 52.604

52.604 - 52.925

Close:

54.415 - 55.073

55.073 - 55.561

Technical analysis  (as of: 2018-05-21 4:33:52 PM)

Overall:

      

Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 68.97     One year: 80.56

Support:

Support1: 49.63    Support2: 43.80

Resistance:

Resistance1: 59.05    Resistance2: 68.97

Pivot:

51.44

Moving Averages:

MA(5): 56.81     MA(20): 50.40

MA(100): 44.10     MA(250): 42.33

MACD:

MACD(12,26): 2.90     Signal(12,26,9): 2.24

%K %D:

%K(14,3): 79.13     %D(3): 85.85

RSI:

RSI(14): 65.13

52-Week:

High: 59.05  Low: 33.3  Change(%): 59.2

Average Vol(K):

3-Month: 75714  10-Days 123921

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
SUPN has closed below upper band by 33.1%. Bollinger Bands are 222.4% wider than normal. The large width of the bands suggest high volatility as compared to SUPN's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.

Headline News

2018-05-15T08:28:41-04:00
Biotechs Emerge Unscathed And Ready To Go!

2018-05-09T13:12:10-04:00
Supernus Pharmaceuticals' (SUPN) CEO, Jack Khattar on Q1 2018 Results - Earnings Call Transcript

2018-05-08T16:42:24-04:00
Supernus Pharmaceuticals beats by $0.16, beats on revenue

2018-05-07T17:35:34-04:00
Notable earnings after Tuesday's close

2018-05-03T00:54:16-04:00
How To Play 'Am I Diversified?' In The Pharma/Biotech Space

2018-04-13T09:17:12-04:00
Biotechs, Whipsawed By Volatility, Still Remain Well-Positioned

2018-03-29T04:21:00-04:00
Looking For Action? S&P 1500 Most Volatile Stocks

2018-03-16T08:00:00-04:00
Your Daily Pharma Scoop: Abeona Update, Alexion Data, Solid Biosciences Setback

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Specialty Advanced Pharmaceuticals

Shares Out. (M)

51.77

Shares Float (M)

50.88

% Held by Insiders

1.70

% Held by Institutions

93.90

Shares Short (K)

4480

Shares Short Prior Month (K)

3910

Stock Financials

EPS

1.540

EPS Est. Current Year

1.040

EPS Est. Next Year

1.660

EPS Est. Next Quarter

0.260

Forward EPS

2.670

Book Value (p.s.)

9.660

PEG Ratio

0.75

Profit Margin

22.44

Operating Margin

34.06

Return on Assets (ttm)

12.8

Return on Equity (ttm)

26.3

Qtrly Rev. Growth

57.1

Gross Profit (p.s.)

2.861

Sales Per Share

EBITDA (p.s.)

1.071

Qtrly Earnings Growth

155.90

Operating Cash Flow (M)

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

35.71

P/E Growth Ratio

-0.02

P/BV

5.69

P/S

434298784.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.